• Stem Cells
• 34 min
  1. Stem cells: immortality or a healthy old age?

  • Dr. Jim McWhir
• 40 min
  2. Mouse embryonic stem cells

  • Prof. Sir Martin Evans
• Regenerative Medicine (I)
• 26 min
  3. Stem cells and regenerative medicine

  • Prof. Dame Julia Polak
  • Dr. Anne Bishop
• 27 min
  4. Tissue engineering: the science, the technology and the industry

  • Prof. Robert Nerem
• 41 min
  5. Clinical potential of stem cells

  • Prof. John Martin
• 11 min
  6. Genes and cells therapy

  • Prof. Nagy Habib
• Regenerative Medicine (II)
• 39 min
  7. Stem cell therapy for the treatment of heart failure

  • Dr. James Willerson
• 35 min
  8. Vascular tissue engineering

  • Prof. Robert Nerem
• 43 min
  9. Stem cell biology and neurodegenerative diseases

  • Dr. Ronald McKay
• 17 min
  10. Cartilage stem cells: tools for joint repair?

  • Prof. Charles Archer
• Biotechnology
• 46 min
  11. Stem cell bioprocessing

  • Dr. Sakis Mantalaris
• 68 min
  12. Nanotechnology for tissue engineering

  • Prof. Thomas J. Webster
• 37 min
  13. Materials for tissue engineering

  • Dr. Molly Stevens
  • Mr. Julian George
• Commercialization
• 36 min
  14. Commercialisation of stem cells

  • Dr. Gareth Roberts
• Ethical and Regulatory Considerations
• 44 min
  15. Stem cell ethics

  • Prof. Dame Anne McLaren
• 23 min
  16. The human fertilisation and embryology authority

  • Dame Suzi Leather
• Archived Lectures *These may not cover the latest advances in the field
• 40 min
  17. Bioethics & politics of human embryonic stem cell science in the EU's 6th framework programme

  • Prof. Brian Salter

Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Stem cells: revolution in medicine
3. Organ regeneration - amphibians and mammals
4. Translation in order of probable success
5. Present results of clinical research
6. Different types of multi-potential stem cells
7. Novel problems in stem cell translational science
8. Traditional pharmacology vs. stem cells repair
9. Stem cells repair: the differences between organs
10. Mechanism of efficacy
11. Animal studies data - for and against stem cells
12. Human studies data - for and against stem cells
13. Lack of intellectual property
14. Cardiac therapeutics: small molecules
15. Gene therapy
16. Stem cell therapy
17. Doctors lead clinical development
18. Confusion among regulators
19. Interest among politicians: positive and negative
20. Present situation
21. Female heart transplanted to male:cell infiltration
22. The clinical trials - routes of stem cells delivery
23. Top Care - AMI studies - protocol
24. Top Care study: results
25. Top Care study: safety and clinical outcome
26. Summary of data from three studies
27. Plan for future clinical research
28. Gene transfer to stem cells
29. Conclusion

Topics Covered

• Amphibians and organ repair
• Application of different cell types to the heart in animal models
• Stem cell repair is complex
• The mechanism of efficacy is unknown
• Intellectual property in autologous stem cells
• Autologous bone marrow cells can cause an increase in ejection fraction after myocardial infarction
• Definitive randomised, controlled, blinded trials are needed
• Gene therapy plus stem cell therapy is the future

Links

Series:

• Stem Cells and Regenerative Medicine

Categories:

• Cell Biology

Talk Citation

Publication History

• Published on October 1, 2007

Financial Disclosures

• Prof. John Martin has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.